Example: Heart Attack

Clinical Trials Sponsored by Eli Lilly and Company

Total 2536 results

NCT06046729

Not yet recruiting

A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa
NCT06049108

Not yet recruiting

A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants

Healthy
NCT06047548

Not yet recruiting

A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Obesity | Overweight
NCT06045221

Not yet recruiting

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin (ACHIEVE-3)

Type 2 Diabetes
NCT06039826

Not yet recruiting

A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese

Overweight
NCT06037252

Not yet recruiting

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

Obesity | Type 2 Diabetes
NCT06028425

Recruiting

A Study to Evaluate the Effect of Food on LOXO-783 in Healthy Participants

Healthy
NCT06025747

Not yet recruiting

Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma

Retroperitoneal Sarcoma
NCT06023095

Not yet recruiting

A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities

Obesity | Overweight
NCT06010004

Not yet recruiting

A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes (ACHIEVE-J)

Type 2 Diabetes
NCT06009653

Recruiting

Effect of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity (TRZ)

Obesity | Metabolic Disease
NCT06007638

Not yet recruiting

A Study of LY3876602 in Healthy Participants

Healthy
NCT06007937

Recruiting

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

Non Small Cell Lung Cancer | Metastatic | Recurrent
NCT06007651

Recruiting

A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)

Dyslipidemias | Non-Alcoholic Fatty Liver Disease
NCT06003465

Not yet recruiting

A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices

Healthy
NCT05999994

Recruiting

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer (CAMPFIRE)

Adolescent | Neoplasms | Child
NCT06001762

Not yet recruiting

TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer

Breast Cancer | Early-stage Breast Cancer | High Risk Breast Carcinoma
NCT05999968

Not yet recruiting

Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

Prostatic Neoplasms
NCT05986292

Recruiting

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain (CPMP)

Chronic Low-back Pain | Osteoarthritis, Knee | Diabetic Neuropathic Pain
NCT05985954

Not yet recruiting

Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy

Metastatic Colorectal Cancer
NCT05978713

Not yet recruiting

A Study of Tirzepatide (LY3298176) in Healthy Lactating Females

Healthy
NCT05980000

Not yet recruiting

Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma (Rambro2)

Recurrent Head and Neck Carcinoma | Recurrent Head and Neck Squamous Cell Carcinoma | HNSCC | Recurrent Head and Neck Cancer | Metastatic Head and Neck Cancer | Metastatic Head-and-neck Squamous-cell Carcinoma
NCT05974579

Not yet recruiting

Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis
NCT05971940

Not yet recruiting

A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (ACHIEVE-1)

Type 2 Diabetes
NCT05960851

Recruiting

A Study of LY3871801 in Healthy Asian and Non-Asian Participants

Healthy
NCT05963022

Recruiting

A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)

Type 2 Diabetes
NCT05959096

Recruiting

A Study of LY3437943 in Healthy Participants With a High Body Mass Index

Healthy
NCT05959109

Recruiting

A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy Participants

Healthy
NCT05940493

Not yet recruiting

Abemaciclib in Newly Diagnosed Meningioma Patients

Meningioma
NCT05936138

Recruiting

A Study of LY3502970 in Participants With Normal and Impaired Renal Function

Healthy | Renal Insufficiency
NCT05936151

Recruiting

A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Type 2 Diabetes | CKD | Overweight or Obesity
NCT05932446

Recruiting

A Study to Compare Two Formulations of LY3819469 in Healthy Participants

Healthy
NCT05931380

Recruiting

A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease (ATTAIN-J)

Obesity
NCT05931367

Recruiting

A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee (TRIUMPH-4)

Obesity | Overweight | Osteo Arthritis Knee
NCT05929066

Recruiting

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight (TRIUMPH-1)

Obesity | Overweight | Knee Osteoarthritis | Obstructive Sleep Apnea | Knee Pain Chronic
NCT05929079

Recruiting

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2)

Obesity | Overweight | Obstructive Sleep Apnea | Type 2 Diabetes
NCT05918666

Recruiting

National Register of Actionable Mutations (RATIONAL)

Solid Tumours in Advanced Stages
NCT05916560

Recruiting

A Study of LY3437943 in Participants With Impaired and Normal Liver Function

Hepatic Insufficiency | Healthy
NCT05911841

Recruiting

A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis
NCT05914688

Recruiting

A Study to Compare Two Formulations of LY3209590 in Healthy Participants

Healthy
NCT05912621

Not yet recruiting

Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity

Obesity | Overweight | Overweight and Obesity
NCT05906836

Recruiting

A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants

Healthy
NCT05894928

Recruiting

A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants

Healthy
NCT05893797

Not yet recruiting

A Study of LY8888AX in Participants Using a Connected Insulin Management Platform

Type 1 Diabetes | Type 2 Diabetes | Type 2 Diabetes Treated With Insulin
NCT05887999

Recruiting

A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1
NCT05882032

Recruiting

A Study of LY3502970 in Participants With Impaired and Normal Liver Function

Hepatic Insufficiency | Healthy
NCT05882045

Recruiting

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)

Cardiovascular Diseases | Obesity
NCT05872620

Recruiting

A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes (ATTAIN-2)

Obesity | Overweight | Type 2 Diabetes
NCT05872204

Not yet recruiting

Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer (ALEPRO)

Low Grade Serous Ovarian Carcinoma | Adult Type Granulosa Cell Tumor
NCT05869903

Recruiting

A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-1)

Obesity | Overweight | Overweight or Obesity

Clinical Trials Sponsored by Eli Lilly and Company

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations